Philip T. Cagle, M.D.: "there is now great hope where once there was little hope for patients with lung cancer"

http://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2012-0382-ED

SPECIAL SECTION—HOUSTON LUNG SYMPOSIUM

The Transformation of Pathology: Proceedings of the Houston Lung Symposium

Philip T. Cagle, MD

From the Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, Texas.

Archives of Pathology & Laboratory Medicine: October 2012, Vol. 136, No. 10, pp. 1184-1185.

"Diagnosis and treatment of lung cancer have undergone a major transformation during the past few years, generating tremendous excitement among physicians and patients. Although many of these advances are still in early stages, overall, there is now great hope where once there was little hope for patients with lung cancer. The advent of clinically meaningful molecular targeted therapies and corresponding predictive biomarkers, advanced imaging techniques for in vivo diagnosis, as well as new developments in screening, staging, and classification of lung cancer, have all contributed to this revolution in diagnosis and treatment of the leading cause of cancer deaths in the United States and worldwide."